Movement Alert|Oscar Health, Inc. Rises 5.41% in Regular Trading, ACA Subsidy Extension Policy Continues to Fuel Gains

Market Focus09-17

On September 17, Oscar Health, Inc. rose 5.41% in regular trading, trading at $34.065 per share, with turnover of $44.78 million. The stock continued to rally on the back of policy tailwinds from the White House proposal to extend Affordable Care Act subsidies by two years.

The proposed ACA subsidy extension directly benefits Oscar Health, Inc., which offers health plans through the ACA marketplace. The policy catalyst had previously driven shares up more than 20% in a single session, and the current move reflects a continuation of that momentum. Meanwhile, BofA Securities raised its price target on the stock to $30 from $28 while maintaining an Underperform rating, and the analyst consensus mean target stands at $34.64.

Fundamentally, Oscar Health, Inc. reported strong Q2 results, with revenue of $4.88 billion surpassing the $4.75 billion estimate and EPS of $1.10 far exceeding the $0.49 consensus. Total membership surged 46% year-over-year to 2.963 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above analyst expectations. However, management cautioned that ACA membership churn could accelerate in the second half.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment